129 related articles for article (PubMed ID: 37457799)
1. Formulation and Evaluation of PLGA Nanoparticulate-Based Microneedle System for Potential Treatment of Neurological Diseases.
Li B; Lu G; Liu W; Liao L; Ban J; Lu Z
Int J Nanomedicine; 2023; 18():3745-3760. PubMed ID: 37457799
[TBL] [Abstract][Full Text] [Related]
2. Mechanical strength affecting the penetration in microneedles and PLGA nanoparticle-assisted drug delivery: Importance of preparation and formulation.
Lu G; Li B; Lin L; Li X; Ban J
Biomed Pharmacother; 2024 Apr; 173():116339. PubMed ID: 38428314
[TBL] [Abstract][Full Text] [Related]
3. Novel bilayer dissolving microneedle arrays with concentrated PLGA nano-microparticles for targeted intradermal delivery: Proof of concept.
Vora LK; Donnelly RF; Larrañeta E; González-Vázquez P; Thakur RRS; Vavia PR
J Control Release; 2017 Nov; 265():93-101. PubMed ID: 29037785
[TBL] [Abstract][Full Text] [Related]
4. Microneedle/nanoencapsulation-mediated transdermal delivery: mechanistic insights.
Gomaa YA; Garland MJ; McInnes FJ; Donnelly RF; El-Khordagui LK; Wilson CG
Eur J Pharm Biopharm; 2014 Feb; 86(2):145-55. PubMed ID: 23461860
[TBL] [Abstract][Full Text] [Related]
5. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
[TBL] [Abstract][Full Text] [Related]
6. Mathematical modelling of microneedle-mediated transdermal delivery of drug nanocarriers into skin tissue and circulatory system.
Newell B; Zhan W
J Control Release; 2023 Aug; 360():447-467. PubMed ID: 37429359
[TBL] [Abstract][Full Text] [Related]
7. Microneedle mediated delivery of nanoparticles into human skin.
Coulman SA; Anstey A; Gateley C; Morrissey A; McLoughlin P; Allender C; Birchall JC
Int J Pharm; 2009 Jan; 366(1-2):190-200. PubMed ID: 18812218
[TBL] [Abstract][Full Text] [Related]
8. Delving Deeper into Dermal and Transdermal Drug Delivery: Factors and Mechanisms Associated with Nanocarrier-mediated Strategies.
Manikkath J; Sumathy TK; Manikkath A; Mutalik S
Curr Pharm Des; 2018; 24(27):3210-3222. PubMed ID: 30246632
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of cilnidipine loaded PLGA nanoparticles: process optimization by DoE, physico-chemical characterization and in vivo evaluation.
Diwan R; Khan S; Ravi PR
Drug Deliv Transl Res; 2020 Oct; 10(5):1442-1458. PubMed ID: 32329025
[TBL] [Abstract][Full Text] [Related]
10. Flexible two-layer dissolving and safing microneedle transdermal of neurotoxin: A biocomfortable attempt to treat Rheumatoid Arthritis.
Yao W; Tao C; Zou J; Zheng H; Zhu J; Zhu Z; Zhu J; Liu L; Li F; Song X
Int J Pharm; 2019 May; 563():91-100. PubMed ID: 30890451
[TBL] [Abstract][Full Text] [Related]
11. Utilization of PLGA nanoparticles in yeast cell wall particle system for oral targeted delivery of exenatide to improve its hypoglycemic efficacy.
Ren T; Zheng X; Bai R; Yang Y; Jian L
Int J Pharm; 2021 May; 601():120583. PubMed ID: 33839225
[TBL] [Abstract][Full Text] [Related]
12. Polymer Nanoparticles with 2-HP-β-Cyclodextrin for Enhanced Retention of Uptake into HCE-T Cells.
Qin Z; Li B; Deng Q; Wen Y; Feng S; Duan C; Zhao B; Li H; Gao Y; Ban J
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338402
[TBL] [Abstract][Full Text] [Related]
13. Microneedle Array Patch (MAP) Consisting of Crosslinked Hyaluronic Acid Nanoparticles for Processability and Sustained Release.
Kim DS; Choi JT; Kim CB; Shin YR; Park PG; Kim H; Lee JM; Park JH
Pharm Res; 2020 Feb; 37(3):50. PubMed ID: 32034526
[TBL] [Abstract][Full Text] [Related]
14. Nanoformulation of Paclitaxel: Exploring the Cyclodextrin / PLGA Nano Delivery Carrier to Slow Down Paclitaxel Release, Enhance Accumulation
Ma P; Huang J; Liu J; Zhu Y; Chen J; Chen J; Lei L; Guan Z; Ban J; Lu Z
J Cancer; 2023; 14(5):759-769. PubMed ID: 37056390
[No Abstract] [Full Text] [Related]
15. [Preparation of triptolide-loaded dissolving microneedles and its transdermal penetration].
Chen X; Zhang YP; Xu J; Song XL; Liu Y; Guo L; Wang ZH
Zhongguo Zhong Yao Za Zhi; 2021 Oct; 46(20):5278-5283. PubMed ID: 34738430
[TBL] [Abstract][Full Text] [Related]
16. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
[TBL] [Abstract][Full Text] [Related]
17. Effect of microneedle treatment on the skin permeation of a nanoencapsulated dye.
Gomaa YA; El-Khordagui LK; Garland MJ; Donnelly RF; McInnes F; Meidan VM
J Pharm Pharmacol; 2012 Nov; 64(11):1592-602. PubMed ID: 23058046
[TBL] [Abstract][Full Text] [Related]
18.
Nigam K; Kaur A; Tyagi A; Manda K; Goswami N; Nematullah M; Khan F; Gabrani R; Gauba P; Dang S
J Microencapsul; 2022 Mar; 39(2):95-109. PubMed ID: 35147068
[TBL] [Abstract][Full Text] [Related]
19. Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.
Patil GB; Surana SJ
J Biomater Sci Polym Ed; 2013; 24(15):1740-56. PubMed ID: 23705812
[TBL] [Abstract][Full Text] [Related]
20. Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting.
Jafarieh O; Md S; Ali M; Baboota S; Sahni JK; Kumari B; Bhatnagar A; Ali J
Drug Dev Ind Pharm; 2015; 41(10):1674-81. PubMed ID: 25496439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
